Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Anderson

Concepts (103)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Venous Thromboembolism
12
2025
324
2.400
Why?
Aspirin
4
2018
399
1.140
Why?
Anticoagulants
11
2025
722
1.110
Why?
Arthroplasty, Replacement, Hip
3
2018
182
1.100
Why?
Platelet Aggregation Inhibitors
4
2018
497
1.080
Why?
Dalteparin
2
2013
10
0.800
Why?
Hematology
2
2020
21
0.770
Why?
Venous Thrombosis
5
2020
194
0.540
Why?
Surgical Procedures, Operative
1
2019
270
0.500
Why?
Factor Xa Inhibitors
1
2018
187
0.480
Why?
Rivaroxaban
1
2018
267
0.460
Why?
Pulmonary Embolism
4
2020
244
0.410
Why?
Arthroplasty, Replacement, Knee
1
2018
370
0.380
Why?
Hemorrhage
4
2025
809
0.350
Why?
Postoperative Complications
2
2021
2919
0.290
Why?
Warfarin
2
2008
170
0.270
Why?
Thrombophilia
2
2022
88
0.250
Why?
Catheterization, Central Venous
1
2005
122
0.190
Why?
Myocardial Ischemia
1
2024
285
0.180
Why?
Postthrombotic Syndrome
2
2013
13
0.170
Why?
Double-Blind Method
4
2018
2029
0.160
Why?
History, 21st Century
1
2019
219
0.140
Why?
Risk Factors
8
2025
10779
0.140
Why?
Healthcare Disparities
1
2025
727
0.140
Why?
Models, Statistical
1
2021
681
0.130
Why?
Humans
20
2025
144759
0.110
Why?
Ticlopidine
1
2015
54
0.110
Why?
Dyspnea
1
2016
251
0.110
Why?
Exercise Tolerance
1
2016
283
0.110
Why?
Middle Aged
10
2025
35875
0.100
Why?
Stockings, Compression
1
2013
5
0.100
Why?
Intermittent Claudication
1
2015
121
0.100
Why?
Practice Guidelines as Topic
1
2021
1560
0.100
Why?
Aged
9
2025
25913
0.100
Why?
Oxygen Consumption
1
2016
724
0.100
Why?
Activities of Daily Living
1
2016
441
0.100
Why?
Male
12
2025
72315
0.100
Why?
Recurrence
4
2021
1135
0.090
Why?
Ischemia
1
2015
421
0.090
Why?
Drug Administration Schedule
1
2013
779
0.080
Why?
Health Status
1
2016
836
0.080
Why?
Adult
10
2025
40449
0.080
Why?
Prospective Studies
5
2025
7990
0.080
Why?
Hospitalization
1
2019
2433
0.070
Why?
Patient Selection
1
2013
719
0.070
Why?
Neoplasms
2
2020
2875
0.070
Why?
Female
11
2025
78271
0.070
Why?
Peripheral Arterial Disease
1
2015
503
0.070
Why?
Canada
3
2016
428
0.070
Why?
Factor V
2
2022
26
0.070
Why?
Treatment Outcome
5
2025
11679
0.060
Why?
United States
3
2020
15966
0.060
Why?
Physical Examination
1
2008
239
0.060
Why?
Predictive Value of Tests
3
2020
2115
0.060
Why?
Placebos
1
2005
192
0.050
Why?
Catheters, Indwelling
1
2005
96
0.050
Why?
Quality of Life
1
2016
3185
0.050
Why?
Risk Assessment
2
2025
3671
0.050
Why?
Incidence
2
2025
2879
0.050
Why?
Cohort Studies
3
2021
5960
0.050
Why?
Electrocardiography, Ambulatory
1
2024
64
0.050
Why?
Prothrombin
1
2022
25
0.050
Why?
Cardiovascular Diseases
1
2015
2168
0.050
Why?
Radiography
1
2005
844
0.050
Why?
Aged, 80 and over
3
2015
8265
0.040
Why?
Contraceptive Agents
1
2021
65
0.040
Why?
Electrocardiography
1
2024
662
0.040
Why?
Time Factors
2
2025
7173
0.040
Why?
Fibrin Fibrinogen Degradation Products
1
2020
93
0.040
Why?
Trust
1
2021
153
0.040
Why?
Diagnosis, Differential
1
2024
1489
0.040
Why?
Probability
1
2020
310
0.040
Why?
Neurosurgical Procedures
1
2020
202
0.030
Why?
Perfusion Imaging
1
2016
65
0.030
Why?
Walk Test
1
2016
80
0.030
Why?
Ultrasonography
1
2020
770
0.030
Why?
Evidence-Based Medicine
1
2020
732
0.030
Why?
Computed Tomography Angiography
1
2016
145
0.030
Why?
Platelet Function Tests
1
2015
34
0.030
Why?
Neoplasm Recurrence, Local
1
2021
1137
0.030
Why?
Chi-Square Distribution
1
2015
529
0.030
Why?
Exercise Test
1
2016
634
0.020
Why?
Echocardiography
1
2016
652
0.020
Why?
California
1
2015
475
0.020
Why?
Severity of Illness Index
2
2013
2925
0.020
Why?
Propensity Score
1
2015
367
0.020
Why?
Point-of-Care Systems
1
2015
187
0.020
Why?
Kaplan-Meier Estimate
1
2015
965
0.020
Why?
Drug Therapy, Combination
1
2015
1047
0.020
Why?
Proportional Hazards Models
1
2015
1325
0.020
Why?
Mutation
1
2022
4089
0.020
Why?
Pulmonary Artery
1
2016
1134
0.020
Why?
Combined Modality Therapy
1
2013
1266
0.020
Why?
Critical Illness
1
2015
891
0.020
Why?
Health Status Indicators
1
2008
166
0.020
Why?
Observer Variation
1
2008
355
0.020
Why?
Follow-Up Studies
1
2016
5408
0.020
Why?
Registries
1
2015
2385
0.010
Why?
Adolescent
1
2005
22428
0.010
Why?
Dose-Response Relationship, Drug
1
2008
2027
0.010
Why?
Reproducibility of Results
1
2008
3409
0.010
Why?
Genetic Predisposition to Disease
1
2008
2363
0.010
Why?
Surveys and Questionnaires
1
2008
6048
0.010
Why?
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)